BUSINESS● LOW1h ago · Nov 3, 2026, 2:59 AM
Jazz outlines $4.775B-$4.85B 2026 revenue guidance as Ziihera launch builds toward $3B-$5B peak sales potential
Seeking Alpha Tech · global
Jazz Pharmaceuticals has provided revenue guidance for 2026, projecting between $4.775 billion and $4.85 billion. This forecast is driven by the anticipated launch of Ziihera, which has a peak sales potential of $3 billion to $5 billion.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS21m agoWhy financial empowerment is the UK’s next great economic opportunityPolitico EuropeBUSINESS24m agoJohn Hancock Preferred Income Fund III declares $0.11 dividendSeeking Alpha Tech